Net income
-222 million USD
2024-07-01 – 2025-06-30
Fundies. English
CARGO Therapeutics, Inc.
EDGAR12 filing records in this dataset, filed from 2023-10-20 to 2025-08-06. Reported financial figures are available; chart coverage varies by period.
- Cash and cash equivalents
- 108 million USD Source
Exact value
107746000 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 46 million shares Source
Exact value
46042504 shares
Reported share-count change
11.74% · 4.84 million shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Operating cash flow
-190 million USD
2024-07-01 – 2025-06-30
Exact inputs and evidence
- Operating cash flow: -104900000 USD · 2024-01-01 – 2024-09-30 Source
- Operating cash flow: -65230000 USD · 2024-01-01 – 2024-06-30 Source
- Operating cash flow: -139700000 USD · 2024-01-01 – 2024-12-31 Source
- Operating cash flow: -104900000 USD · 2024-01-01 – 2024-09-30 Source
- Operating cash flow: -37700000 USD · 2025-01-01 – 2025-03-31 Source
- Operating cash flow: -115100000 USD · 2025-01-01 – 2025-06-30 Source
- Operating cash flow: -37700000 USD · 2025-01-01 – 2025-03-31 Source
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2025-08-06.
Financial data available through: 2024-12-31.
Coverage by financial measure
- revenue: No compatible figures in this window
- Operating income: 3 of 11 periods available· newest 2024-12-31
- Net income: 3 of 11 periods available· newest 2024-12-31
- Operating cash flow: 3 of 11 periods available· newest 2024-12-31
- Capital expenditure: 2 of 11 periods available· newest 2024-12-31
- Total assets: 3 of 11 periods available· newest 2024-12-31
- Total liabilities: 3 of 11 periods available· newest 2024-12-31
- Current assets: 3 of 11 periods available· newest 2024-12-31
- Current liabilities: 3 of 11 periods available· newest 2024-12-31
- Cash and cash equivalents: 3 of 11 periods available· newest 2024-12-31
- long term debt: No compatible figures in this window
- Shares outstanding: 3 of 11 periods available· newest 2024-12-31
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
−USD 69.36 millionPrior period
−USD 98.15 million
–
Current period
−USD 167.5 million
–
Exact inputs and evidence
-167502000 − -98147000 = -69355000 USD
-98147000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source-167502000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 58.54 millionPrior period
−USD 81.16 million
–
Current period
−USD 139.7 million
–
Exact inputs and evidence
-139700000 − -81164000 = -58536000 USD
-81164000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source-139700000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-46.3%Prior period
USD 8.28 million
–
Current period
USD 4.45 million
–
Exact inputs and evidence
4447000 − 8277000 = -3830000 USD
8277000 USD · 2023-01-01 – 2023-12-31
Inspect prior input Prior source4447000 USD · 2024-01-01 – 2024-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Not enough comparable data to show this history.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Not enough comparable data to show this history.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2022 2022-01-01 – 2022-12-31 | −USD 40.95 million Exact valueExact value: -40951000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 29.07 million Exact valueExact value: -29072000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2023 2023-01-01 – 2023-12-31 | −USD 98.15 million Exact valueExact value: -98147000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 81.16 million Exact valueExact value: -81164000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 8.28 million Exact valueExact value: 8277000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 89.44 million Calculation and evidence-81164000 − 8277000 USD Exact free cash flow: -89441000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2024-01-01 – 2024-12-31 | −USD 167.5 million Exact valueExact value: -167502000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 139.7 million Exact valueExact value: -139700000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 4.45 million Exact valueExact value: 4447000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 144.15 million Calculation and evidence-139700000 − 4447000 USD Exact free cash flow: -144147000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
12 filings · 578 latest values · 578 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001966494, 1966494, CRGX, edgar:1966494
Also known as CARGO Therapeutics, Inc.